Laura Jeanette Yockey, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 8 | 2021 | 2185 | 1.110 |
Why?
|
Vaginal Discharge | 1 | 2021 | 25 | 0.760 |
Why?
|
Vaginitis | 1 | 2021 | 50 | 0.750 |
Why?
|
Maternal-Fetal Exchange | 2 | 2020 | 462 | 0.740 |
Why?
|
Vaginosis, Bacterial | 1 | 2022 | 151 | 0.720 |
Why?
|
Fetal Development | 3 | 2020 | 771 | 0.570 |
Why?
|
Vagina | 4 | 2023 | 845 | 0.560 |
Why?
|
Fetus | 4 | 2021 | 1883 | 0.540 |
Why?
|
Fetal Death | 1 | 2018 | 438 | 0.510 |
Why?
|
Fetal Growth Retardation | 2 | 2018 | 591 | 0.510 |
Why?
|
Fetal Diseases | 1 | 2020 | 916 | 0.470 |
Why?
|
Interferons | 1 | 2018 | 716 | 0.470 |
Why?
|
Virus Diseases | 1 | 2020 | 723 | 0.450 |
Why?
|
Interferon Type I | 1 | 2018 | 569 | 0.440 |
Why?
|
Placenta | 6 | 2021 | 1723 | 0.410 |
Why?
|
Virus Replication | 3 | 2017 | 2458 | 0.410 |
Why?
|
Cytokines | 3 | 2018 | 7445 | 0.400 |
Why?
|
Receptor, Interferon alpha-beta | 4 | 2018 | 113 | 0.340 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1890 | 0.330 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2257 | 0.320 |
Why?
|
Pregnancy | 10 | 2021 | 30200 | 0.290 |
Why?
|
Brain Diseases | 1 | 2016 | 1552 | 0.280 |
Why?
|
Specimen Handling | 2 | 2020 | 708 | 0.250 |
Why?
|
Lactobacillus | 2 | 2023 | 212 | 0.240 |
Why?
|
Skin | 3 | 2013 | 4499 | 0.240 |
Why?
|
Pregnancy Complications | 1 | 2018 | 2972 | 0.230 |
Why?
|
Fetal Blood | 2 | 2021 | 1361 | 0.230 |
Why?
|
Hypersensitivity | 1 | 2013 | 1173 | 0.220 |
Why?
|
Glycerol | 1 | 2022 | 274 | 0.190 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 112 | 0.170 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2021 | 1360 | 0.170 |
Why?
|
Serine Endopeptidases | 2 | 2021 | 1026 | 0.160 |
Why?
|
Antibodies, Viral | 2 | 2020 | 3211 | 0.160 |
Why?
|
Humidity | 1 | 2019 | 206 | 0.150 |
Why?
|
Orthomyxoviridae Infections | 1 | 2019 | 255 | 0.130 |
Why?
|
Abortion, Habitual | 1 | 2016 | 61 | 0.130 |
Why?
|
Respiratory Mucosa | 1 | 2019 | 439 | 0.130 |
Why?
|
Immunity, Mucosal | 1 | 2019 | 493 | 0.130 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2016 | 146 | 0.120 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11918 | 0.120 |
Why?
|
Uterus | 1 | 2018 | 661 | 0.110 |
Why?
|
Testis | 1 | 2017 | 783 | 0.110 |
Why?
|
Inflammation | 1 | 2013 | 10863 | 0.110 |
Why?
|
Mice, Mutant Strains | 1 | 2016 | 1755 | 0.110 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.100 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2013 | 133 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.100 |
Why?
|
Female | 17 | 2023 | 397089 | 0.100 |
Why?
|
RNA, Viral | 2 | 2020 | 2866 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1794 | 0.100 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4570 | 0.100 |
Why?
|
Colitis, Ulcerative | 1 | 2023 | 1929 | 0.090 |
Why?
|
Patient Participation | 1 | 2020 | 1448 | 0.090 |
Why?
|
Maternal Exposure | 1 | 2018 | 1079 | 0.090 |
Why?
|
Disease Models, Animal | 4 | 2019 | 18362 | 0.090 |
Why?
|
Immunity, Innate | 2 | 2020 | 3078 | 0.090 |
Why?
|
Mice | 9 | 2019 | 82017 | 0.090 |
Why?
|
Brain | 2 | 2017 | 27454 | 0.090 |
Why?
|
Mice, Inbred C57BL | 3 | 2018 | 22355 | 0.080 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1628 | 0.080 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2961 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2442 | 0.080 |
Why?
|
Animals | 10 | 2019 | 169337 | 0.080 |
Why?
|
Keratinocytes | 1 | 2013 | 876 | 0.080 |
Why?
|
Sex Factors | 1 | 2021 | 10654 | 0.070 |
Why?
|
Immunoglobulin E | 1 | 2013 | 1506 | 0.070 |
Why?
|
Mice, Knockout | 4 | 2017 | 14481 | 0.070 |
Why?
|
Influenza A virus | 2 | 2020 | 460 | 0.070 |
Why?
|
Testosterone | 1 | 2017 | 2493 | 0.060 |
Why?
|
Humans | 15 | 2023 | 768393 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4526 | 0.060 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2023 | 1050 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7463 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2017 | 4646 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2020 | 26411 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2812 | 0.050 |
Why?
|
Bacterial Infections | 1 | 2010 | 1397 | 0.050 |
Why?
|
Alleles | 1 | 2013 | 6892 | 0.050 |
Why?
|
Viral Load | 2 | 2020 | 3398 | 0.050 |
Why?
|
Mice, Congenic | 1 | 2019 | 98 | 0.040 |
Why?
|
Wound Healing | 1 | 2010 | 2813 | 0.040 |
Why?
|
Genotype | 1 | 2013 | 13042 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 584 | 0.040 |
Why?
|
Perinatal Care | 1 | 2020 | 245 | 0.040 |
Why?
|
Young Adult | 2 | 2021 | 60049 | 0.040 |
Why?
|
Tropism | 1 | 2017 | 44 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2020 | 564 | 0.040 |
Why?
|
Injections, Intraperitoneal | 1 | 2017 | 413 | 0.030 |
Why?
|
Adult | 5 | 2021 | 223640 | 0.030 |
Why?
|
Male | 7 | 2021 | 364902 | 0.030 |
Why?
|
Pandemics | 3 | 2020 | 8753 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1528 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1003 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2012 | 5857 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15939 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2021 | 81801 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2020 | 2448 | 0.020 |
Why?
|
Atrophy | 1 | 2017 | 1648 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2017 | 2695 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2017 | 1033 | 0.020 |
Why?
|
Dermatitis | 1 | 2012 | 203 | 0.020 |
Why?
|
Central Nervous System | 1 | 2017 | 1346 | 0.020 |
Why?
|
Staphylococcus | 1 | 2010 | 146 | 0.020 |
Why?
|
Genes, ras | 1 | 2012 | 665 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7598 | 0.020 |
Why?
|
Receptors, Leptin | 1 | 2010 | 350 | 0.020 |
Why?
|
Aged | 1 | 2021 | 171562 | 0.020 |
Why?
|
Population Dynamics | 1 | 2010 | 314 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4266 | 0.020 |
Why?
|
Infant | 2 | 2020 | 36510 | 0.020 |
Why?
|
Influenza, Human | 1 | 2019 | 1539 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2012 | 751 | 0.020 |
Why?
|
Biodiversity | 1 | 2010 | 346 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2012 | 731 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 42650 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8902 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14784 | 0.020 |
Why?
|
Middle Aged | 1 | 2021 | 223491 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9562 | 0.020 |
Why?
|
Metagenome | 1 | 2010 | 465 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2010 | 12241 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10588 | 0.020 |
Why?
|
Age Factors | 1 | 2020 | 18471 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2010 | 2728 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22296 | 0.010 |
Why?
|
Child | 2 | 2020 | 80891 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 89184 | 0.010 |
Why?
|
Host-Pathogen Interactions | 1 | 2010 | 1468 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10844 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2012 | 4411 | 0.010 |
Why?
|
Bacteria | 1 | 2010 | 2221 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2010 | 4775 | 0.010 |
Why?
|
Neurons | 1 | 2017 | 9513 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41795 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17626 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54920 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9510 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23631 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 40272 | 0.000 |
Why?
|